Literature DB >> 8932445

Oxidative degradation of antiflammin 2.

J M Ye1, J L Wolfe.   

Abstract

PURPOSE: To study the oxidation of the methionine residue of antiflammin 2 (HDMNKVLDL, AF2) as a function of pH, buffer concentration, ionic strength, and temperature using different concentrations of hydrogen peroxide and to determine the accessibility of methionine residue to oxidation.
METHODS: Reversed-phase high-performance liquid chromatography (RPHPLC) was used as the main analytical method in determining the oxidation rates of AF2. Calibration curves for AF2 and the oxidation product, methionine sulfoxide of AF2 (Met(O)-3-AF2), were constructed for each measurement using standard materials. Fast Atom Bombardment Mass Spectroscopy (FABMS) was used to characterize the product.
RESULTS: Met(O)-3-AF2 was the only oxidation product detected at pH 3.0 to 8.0. The oxidation rates were independent of buffer concentrations, ionic strength, and pH from 3.0 to 7.0. However, there was an acceleration of the rates at basic pHs, and small amounts of degradation products other than Met(O)-3-AF2 were observed in this alkaline region.
CONCLUSIONS: Oxidation of methionine in AF2 does not cause the biological inactivation reported by other laboratories since this drug is relatively stable under neutral conditions in the absence of oxiding agent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932445     DOI: 10.1023/a:1016095131836

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.

Authors:  J van Binsbergen; A J Slotboom; A J Aarsman; G H de Haas
Journal:  FEBS Lett       Date:  1989-04-24       Impact factor: 4.124

2.  Iron-thiolate induced oxidation of methionine to methionine sulfoxide in small model peptides. Intramolecular catalysis by histidine.

Authors:  C Schöneich; F Zhao; G S Wilson; R T Borchardt
Journal:  Biochim Biophys Acta       Date:  1993-11-28

3.  Degradation of antiflammin 2 in aqueous solution.

Authors:  J L Wolfe; G E Lee; G K Potti; J F Gallelli
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

4.  'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.

Authors:  F Märki; J Pfeilschifter; H Rink; I Wiesenberg
Journal:  FEBS Lett       Date:  1990-05-21       Impact factor: 4.124

5.  Chemical pathways of peptide degradation. V. Ascorbic acid promotes rather than inhibits the oxidation of methionine to methionine sulfoxide in small model peptides.

Authors:  S Li; C Schöneich; G S Wilson; R T Borchardt
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

6.  The kinetics of relaxin oxidation by hydrogen peroxide.

Authors:  T H Nguyen; J Burnier; W Meng
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

7.  Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities.

Authors:  W C Hope; B J Patel; D R Bolin
Journal:  Agents Actions       Date:  1991-09

8.  Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation.

Authors:  S Li; T H Nguyen; C Schöneich; R T Borchardt
Journal:  Biochemistry       Date:  1995-05-02       Impact factor: 3.162

9.  Effects of antiflammins on endotoxin-induced uveitis in rats.

Authors:  C C Chan; M Ni; L Miele; E Cordella-Miele; M Ferrick; A B Mukherjee; R B Nussenblatt
Journal:  Arch Ophthalmol       Date:  1991-02

10.  Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.

Authors:  G Camussi; C Tetta; F Bussolino; C Baglioni
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.